Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression response

BMC Gastroenterology

Juan Lucio Iovanna²  Jean Charles Dagorn²  Daniel Closa¹  Fritz Fiedler³  Patrice Berthézène²  Laure Saint-Michel²  Marc Barthet²  Andrés Garcia-Montero²  Albrecht Hoffmeister²  Sophie Vasseur² 

[1] Department of Experimental Pathology. IDIBAPS; IIBB-CSIC, 08036 Barcelona, Spain;Centre de Recherche INSERM, EMI 0116, 163 Avenue de Luminy, 13009 Marseille, France;Institut für Anästhesie, Klinikum Mannheim, Theodor-Kutzer-Ufer, D-68167, Mannheim, Germany

关键词: mice;    gene expression;    microarray;    LPS;    p8;   

Others  :  1215877
DOI  :  10.1186/1471-230X-3-25

 received in 2003-03-27, accepted in 2003-09-08,  发布年份 2003

【 摘 要 】

Background

p8 is a DNA-binding protein induced in many tissues in response to LPS treatment. Hence, p8 could be a mediator of LPS-associated effects or, on the contrary, p8 expression may be part of the protective mechanism of the tissues in response to LPS. Finally, p8 expression in response to LPS could also be a simple epiphenomenon.

Methods

To investigate the role of p8 in vivo, we generated p8-deficient mice by gene targeting. Because p8 is a stress protein, we analyzed the response of p8^-/- mice to a systemic stress induced by LPS injection. Liver was chosen as model organ to monitor alterations in gene expression.

Results

LPS resulted in higher serum TNF-α concentration and higher mortality rate in p8-deficient mice than in wild-type. Also, liver and pancreas, but not lung, from p8^-/- mice showed increased amounts of MPO and HPO. To gain insight into the molecular bases of such susceptibility, we used high density DNA microarrays consisting of ~6000 genes and ESTs to compare gene regulation in response to LPS in p8^+/+ and p8^-/- livers. In wild-type, 105 genes and 73 ESTs were up-regulated and 232 genes and 138 ESTs down-regulated. By contrast, 212 genes and 125 ESTs were found up-regulated and 90 genes and 85 ESTs down regulated in p8^-/- mice. Among them, only 93 (51 induced and 42 repressed) corresponded to the wild-type pattern, demonstrating that p8 deficiency hinders the normal response to LPS, which may account for the increased sensitivity of p8^-/-mice to the endotoxin.

Conclusions

The large number of genes showing abnormal regulation after LPS suggests that p8 is an important regulatory factor involved in many cellular defence pathways.

【 授权许可】

   
2003 Vasseur et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J, Iovanna JL: Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 1997, 272:32360-32369.
• [2]Vasseur S, Mallo GV, Fiedler F, Bodeker H, Canepa E, Moreno S, Iovanna JL: Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 1999, 259:670-675.
• [3]Encinar JA, Mallo GV, Mizyrycki C, Giono L, Gonzalez-Ros JM, Rico M, Canepa E, Moreno S, Neira JL, Iovanna JL: Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 2001, 276:2742-2751.
• [4]Piekielko A, Drung A, Rogalla P, Schwanbeck R, Heyduk T, Gerharz M, Bullerdiek J, Wisniewski JR: Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem 2001, 276:1984-1992.
• [5]Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002, 72:1084-1091.
• [6]Jiang YF, Vaccaro MI, Fiedler F, Calvo EL, Iovanna JL: Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem Biophys Res Commun 1999, 260:686-690.
• [7]Ree AH, Tvermyr M, Engebraaten O, Rooman M, Rosok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O: Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res 1999, 59:4675-4680.
• [8]Vasseur S, Hoffmeister A, Garcia S, Bagnis C, Dagorn JC, Iovanna JL: p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene. EMBO Rep 2002, 3:165-170.
• [9]Bratland A, Risberg K, Maelandsmo GM, Gutzkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH: Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. Cancer Res 2000, 60:5578-5583.
• [10]Macdonald J, Galley HF, Webster NR: Oxidative stress and gene expression in sepsis. Br J Anaesth 2003, 90:221-232.
• [11]Spolarics Z, Stein DS, Garcia ZC: Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells. Hepatology 1996, 24:691-696.
• [12]Sass G, Heinlein S, Agli A, Bang R, Schumann J, Tiegs G: Cytokine expression in three mouse models of experimental hepatitis. Cytokine 2002, 19:115-120.
• [13]Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, Bianchi ME: The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999, 22:276-280.
• [14]Grosschedl R, Giese K, Pagel J: HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 1994, 10:94-100.
• [15]Reeves R, Nissen MS: Cell cycle regulation and functions of HMG-I(Y). Prog Cell Cycle Res 1995, 1:339-349.
• [16]Bewley CA, Gronenborn AM, Clore GM: Minor groove-binding architectural proteins: structure, function, and DNA recognition. Annu Rev Biophys Biomol Struct 1998, 27:105-131.
• [17]Tallini G, Dal Cin P: HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv Anat Pathol 1999, 6:237-246.
• [18]Hamilton TA, Ohmori Y, Tebo JM, Kishore R: Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology 1999, 67:241-244.
• [19]Forstermann U, Boissel JP, Kleinert H: Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998, 12:773-790.
• [20]Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K: Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
• [21]Ichikawa JK, Norris A, Bangera MG, Geiss GK, van't Wout AB, Bumgarner RE, Lory S: Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc Natl Acad Sci USA 2000, 97:9659-9664.
• [22]Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB: Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol 2000, 164:5894-5904.
• [23]Smith JB, Herschman HR: The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains. Arch Biochem Biophys 1996, 330:290-300.
• [24]Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, de Beer MC, de Beer FC: Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. Arterioscler Thromb 1994, 14:1475-1479.
• [25]Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000, 97:9753-9758.
• [26]Hoffmeister A, Ropolo A, Vasseur S, Mallo GV, Bodeker H, Ritz-Laser B, Dressler GR, Vaccaro MI, Dagorn JC, Moreno S, Iovanna JL: The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter. J Biol Chem 2002, 277:22314-22319.
• [27]Kuhbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R: Temporally controlled somatic mutagenesis in smooth muscle. Genesis 2000, 28:15-22.
• [28]Vasseur S, Hoffmeister A, Garcia-Montero A, Mallo GV, Feil R, Kuhbandner S, Dagorn JC, Iovanna JL: p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 2002, 21:1685-1694.
• [29]de ca J, Cuadrado S, Vallet J, Benasco C, Martin E, Ardanuy C, Closa D, Hotter G, Jaurrieta E: Protective effects of lazaroid U74389G on intestinal graft after heterotopic small bowel transplantation in rats. J Surg Res 1998, 75:18-23.